NO20063320L - Use of gaboxadol for the treatment of insomnia - Google Patents
Use of gaboxadol for the treatment of insomniaInfo
- Publication number
- NO20063320L NO20063320L NO20063320A NO20063320A NO20063320L NO 20063320 L NO20063320 L NO 20063320L NO 20063320 A NO20063320 A NO 20063320A NO 20063320 A NO20063320 A NO 20063320A NO 20063320 L NO20063320 L NO 20063320L
- Authority
- NO
- Norway
- Prior art keywords
- insomnia
- treatment
- gaboxadol
- amount
- patient
- Prior art date
Links
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title abstract 3
- 206010022437 insomnia Diseases 0.000 title abstract 3
- ZXRVKCBLGJOCEE-UHFFFAOYSA-N Gaboxadol Chemical compound C1NCCC2=C1ONC2=O ZXRVKCBLGJOCEE-UHFFFAOYSA-N 0.000 title abstract 2
- 229950004346 gaboxadol Drugs 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Abstract
Den foreliggende oppfirmelse vedrører en fremgangsmåte for å behandle insonmi i en human pasient som trenger det ved å administrere en mengde gaboxadol per dag til pasienten, nevnte mengde er effektiv for behandlingen av insomni.The present invention relates to a method of treating insomnia in a human patient who needs it by administering an amount of gaboxadol per day to the patient, said amount being effective for the treatment of insomnia.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301877 | 2003-12-18 | ||
| PCT/DK2004/000861 WO2005058313A1 (en) | 2003-12-18 | 2004-12-14 | Use of gaboxadol for treating insomnia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063320L true NO20063320L (en) | 2006-07-18 |
Family
ID=34684447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063320A NO20063320L (en) | 2003-12-18 | 2006-07-18 | Use of gaboxadol for the treatment of insomnia |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1720547A1 (en) |
| JP (1) | JP2007515415A (en) |
| KR (1) | KR20060103335A (en) |
| CN (1) | CN1893942A (en) |
| AR (1) | AR047154A1 (en) |
| AU (1) | AU2004298313A1 (en) |
| BR (1) | BRPI0415893A (en) |
| CA (1) | CA2550610A1 (en) |
| EA (1) | EA200600989A1 (en) |
| IL (1) | IL176239A0 (en) |
| IS (1) | IS8390A (en) |
| MX (1) | MXPA06006685A (en) |
| NO (1) | NO20063320L (en) |
| SG (1) | SG133601A1 (en) |
| TW (1) | TW200528098A (en) |
| WO (1) | WO2005058313A1 (en) |
| ZA (1) | ZA200602762B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0402118D0 (en) | 2004-01-30 | 2004-03-03 | Merck Sharp & Dohme | Polymorphic forms of a GABAA agonist |
| US20080262029A1 (en) * | 2005-04-29 | 2008-10-23 | H. Lundbeck A/S | Acid and Base Salt Forms of Gaboxadol |
| IL256912B2 (en) | 2015-07-17 | 2024-01-01 | Ovid Therapeutics Inc | Methods for treating developmental disorders with gaboxadol |
| CN111328282A (en) * | 2017-09-12 | 2020-06-23 | 奥维德医疗公司 | Use of Gaboxadol in the Treatment of Narcolepsy |
| MX2021003302A (en) | 2018-09-20 | 2021-05-13 | Ovid Therapeutics Inc | Use of gaboxadol for the treatment of tourette syndrome, tics and stuttering. |
| EP3880201A4 (en) * | 2018-12-17 | 2022-07-27 | Ovid Therapeutics Inc. | Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder |
| EP4051272A4 (en) | 2019-12-18 | 2023-01-04 | Ovid Therapeutics Inc. | GABOXADOL FOR THE THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19525598C2 (en) * | 1995-07-13 | 1997-09-25 | Max Planck Gesellschaft | sleeping pills |
| CN1511026A (en) * | 2001-05-21 | 2004-07-07 | H��¡�±�������˾ | Gaboxadol Granules |
-
2004
- 2004-12-07 TW TW093137759A patent/TW200528098A/en unknown
- 2004-12-14 CA CA002550610A patent/CA2550610A1/en not_active Abandoned
- 2004-12-14 WO PCT/DK2004/000861 patent/WO2005058313A1/en not_active Ceased
- 2004-12-14 CN CNA2004800372437A patent/CN1893942A/en active Pending
- 2004-12-14 KR KR1020067011921A patent/KR20060103335A/en not_active Withdrawn
- 2004-12-14 EA EA200600989A patent/EA200600989A1/en unknown
- 2004-12-14 BR BRPI0415893-8A patent/BRPI0415893A/en not_active IP Right Cessation
- 2004-12-14 SG SG200704528-9A patent/SG133601A1/en unknown
- 2004-12-14 EP EP04803014A patent/EP1720547A1/en not_active Withdrawn
- 2004-12-14 JP JP2006544213A patent/JP2007515415A/en not_active Withdrawn
- 2004-12-14 MX MXPA06006685A patent/MXPA06006685A/en unknown
- 2004-12-14 AU AU2004298313A patent/AU2004298313A1/en not_active Abandoned
- 2004-12-14 ZA ZA200602762A patent/ZA200602762B/en unknown
- 2004-12-17 AR ARP040104752A patent/AR047154A1/en not_active Application Discontinuation
-
2006
- 2006-03-30 IS IS8390A patent/IS8390A/en unknown
- 2006-06-11 IL IL176239A patent/IL176239A0/en unknown
- 2006-07-18 NO NO20063320A patent/NO20063320L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005058313A1 (en) | 2005-06-30 |
| EA200600989A1 (en) | 2006-10-27 |
| KR20060103335A (en) | 2006-09-28 |
| TW200528098A (en) | 2005-09-01 |
| IL176239A0 (en) | 2006-10-05 |
| AR047154A1 (en) | 2006-01-11 |
| CA2550610A1 (en) | 2005-06-30 |
| CN1893942A (en) | 2007-01-10 |
| JP2007515415A (en) | 2007-06-14 |
| EP1720547A1 (en) | 2006-11-15 |
| MXPA06006685A (en) | 2006-08-23 |
| SG133601A1 (en) | 2007-07-30 |
| IS8390A (en) | 2006-03-30 |
| ZA200602762B (en) | 2007-06-27 |
| AU2004298313A1 (en) | 2005-06-30 |
| BRPI0415893A (en) | 2007-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200501319A1 (en) | METHODS OF TREATMENT OF PATIENTS BY INTRODUCING ANTAGONIST OF NERVES GROWTH FACTOR AND NONSTEROID ANTI-INFLAMMATORY MEANS AND CONTAINING THEIR COMPOSITIONS | |
| EA201000914A1 (en) | NEW THERAPEUTIC APPROACHES IN THE TREATMENT OF SMT AND RELATED DISORDERS | |
| BR0308928A (en) | Use of botulinum toxin for the treatment of cardiovascular disease, as well as composition for use in a cardiovascular procedure. | |
| NO20074999L (en) | Method and preparation for the treatment of peripheral vascular diseases | |
| ATE457166T1 (en) | ORAL COMPOSITIONS FOR TREATING DIABETES | |
| NO20050204L (en) | Combinations of drugs for the treatment of neoplasms | |
| UA94899C2 (en) | Fixed dosing of her antibodies | |
| ATE389411T1 (en) | STRONTIUM COMPOUND FOR THE TREATMENT OF SUB-DERMAL SOFT TISSUE PAIN | |
| DK1263729T3 (en) | Cyclic aza compounds for use in the treatment of serotonin-related diseases | |
| BRPI0510094A (en) | use of flibanserin for premenstrual treatment and other female sexual disorders | |
| NO20083036L (en) | Use of benzofused heterocyclic sulfamide derivatives for the treatment of depression | |
| CY1115690T1 (en) | ARTHROSPIRA BASED COMPOSITIONS AND THEIR USES | |
| DE122009000036I2 (en) | Use of dapoxetine, a selective serotonin uptake inhibitor, for the treatment of sexual dysfunction | |
| DE502005008058D1 (en) | Saturated and unsaturated 3-pyridyl-benzocyclo-cyclo-ethyl-amine for the treatment of pain, depression and anxiety | |
| NO20054371L (en) | Somatostatin-dopamine chimeric analogs | |
| EA200970436A1 (en) | CARBAMATE CONNECTIONS FOR THE TREATMENT OF DEPRESSION | |
| EA200700407A1 (en) | HINAZOLIN DERIVATIVES AND THEIR USE IN THE TREATMENT OF THROMBOCYTHEMIA | |
| PT1631275E (en) | Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen | |
| NO20064964L (en) | Treatment of impaired respiratory function | |
| NO20063320L (en) | Use of gaboxadol for the treatment of insomnia | |
| DE602004031631D1 (en) | USE OF BETAIN FOR THE TREATMENT OF CLAUDICATIO INTERMITTENS | |
| EA200501865A1 (en) | ANALOGUES OF TIOVOLFRAMATOV AND THEIR APPLICATION | |
| DE602004024871D1 (en) | POLYAMINE COMPOUNDS FOR THE TREATMENT OF CHEMOKIN RECEPTOR-MEDIATED DISEASES | |
| BR0111900A (en) | Use of an angiotensin ii type 1 receptor antagonist, pharmaceutical formulation, and methods for treating a vascular headache condition and for treating migraine | |
| MXPA05013975A (en) | Treatment of amyloid- and epileptogenesis-associated diseases. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |